Free Trial

BILL (BILL) Stock Forecast & Price Target

BILL logo
$89.85 -0.06 (-0.07%)
(As of 12/12/2024 ET)

BILL - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
9
Buy
10

Based on 20 Wall Street analysts who have issued ratings for BILL in the last 12 months, the stock has a consensus rating of "Hold." Out of the 20 analysts, 1 has given a sell rating, 9 have given a hold rating, and 10 have given a buy rating for BILL.

Consensus Price Target

$80.78
-10.10% Downside
According to the 20 analysts' twelve-month price targets for BILL, the average price target is $80.78. The highest price target for BILL is $100.00, while the lowest price target for BILL is $45.00. The average price target represents a forecasted downside of -10.10% from the current price of $89.85.
Get the Latest News and Ratings for BILL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for BILL and its competitors.

Sign Up

BILL Analyst Ratings Over Time

TypeCurrent Forecast
12/14/23 to 12/13/24
1 Month Ago
11/14/23 to 11/13/24
3 Months Ago
9/15/23 to 9/14/24
1 Year Ago
12/14/22 to 12/14/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
10 Buy rating(s)
11 Buy rating(s)
15 Buy rating(s)
Hold
9 Hold rating(s)
8 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$80.78$74.65$70.24$116.91
Forecasted Upside-10.10% Downside-16.78% Downside35.30% Upside51.28% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

BILL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BILL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

BILL Stock vs. The Competition

TypeBILLComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.45
2.68
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-10.10% Downside260.63% Upside10.07% Upside
News Sentiment Rating
Neutral News

See Recent BILL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/9/2024Keefe, Bruyette & Woods
4 of 5 stars
 Boost TargetMarket Perform ➝ Market Perform$75.00 ➝ $100.00+7.27%
12/3/2024Robert W. Baird
2 of 5 stars
 Boost TargetNeutral ➝ Neutral$74.00 ➝ $100.00+11.72%
12/2/2024The Goldman Sachs Group
2 of 5 stars
W. Nance
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$77.00 ➝ $96.00+7.80%
11/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$58.00 ➝ $95.00+2.36%
11/8/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$70.00 ➝ $83.00+11.63%
11/8/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$60.00 ➝ $85.00+29.02%
9/12/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Poutrieux
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$90.00+72.28%
8/28/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$60.00 ➝ $52.00-2.77%
8/26/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$75.00 ➝ $57.00+20.41%
8/23/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Levine
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetIn-Line ➝ In-Line$70.00 ➝ $60.00+18.20%
8/23/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$100.00 ➝ $100.00+97.01%
8/23/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$100.00 ➝ $100.00+97.01%
8/20/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$80.00 ➝ $60.00+19.45%
8/20/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$60.00 ➝ $45.00-11.39%
8/19/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingPositive ➝ Positive$100.00 ➝ $100.00+100.08%
8/15/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$85.00 ➝ $65.00+37.89%
8/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Peller
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
5/3/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Roberge
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
4/29/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$95.00 ➝ $80.00+26.26%
2/12/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$85.00 ➝ $86.00+31.30%
11/3/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Sector Weight
10/12/2023Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Cantwell
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
8/18/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$150.00 ➝ $140.00+37.90%
6/29/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
6/29/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$110.00 ➝ $140.00+17.92%
2/6/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$200.00 ➝ $160.00+69.29%
2/3/2023Sumitomo Mitsui Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Neutral$140.00 ➝ $110.00-14.67%
2/3/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:35 AM ET.


BILL Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for BILL is $80.78, with a high forecast of $100.00 and a low forecast of $45.00.

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BILL in the last year. There is currently 1 sell rating, 9 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BILL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BILL, but not buy additional shares or sell existing shares.

According to analysts, BILL's stock has a predicted downside of -10.10% based on their 12-month stock forecasts.

BILL has been rated by research analysts at Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer, Piper Sandler, Robert W. Baird, and The Goldman Sachs Group in the past 90 days.

Analysts like BILL less than other "computer and technology" companies. The consensus rating for BILL is Hold while the average consensus rating for "computer and technology" companies is Moderate Buy. Learn more on how BILL compares to other companies.


This page (NYSE:BILL) was last updated on 12/13/2024 by MarketBeat.com Staff
From Our Partners